Inaktiver Wert

Andere Sprachen Nexstim Oyj Nasdaq Helsinki

Aktien

Health Canada Approves Nexstim NBS 6 System for Treatment of MDD	08:00
Nexstim plc Receives Approval from Health Canada for the Marketing and Commercial Distribution of Its NBS 6 System for the Treatment of Major Depressive Disorder	08:00
Nexstim, Inc. and Inomed Inc. Enter into Strategic Alliance Agreement for US Market	03.05.
Neurosurgery Customer from Germany Orders Nexstim NBS System 5	26.04.
Nexstim plc Receives Order for A New NBS System 5 from an Existing Customer Hospital in Germany	26.04.
Nexstim Plc Business Update Q1 2024	26.04.
Nexstim Plc: Managers’ Transactions, Hildén	25.04.
Nexstim Plc: Managers’ Transactions, Forss	25.04.
Nexstim Plc: Managers’ Transactions, Weckroth	25.04.
Nexstim Plc: Managers’ Transactions, Niemistö	25.04.
Nexstim Wins Order for Navigated Brain Stimulation System in US	22.04.
Nexstim Receives NBS 6 System Order from Clinic in Florida, US	22.04.
Nexstim Receives NBS 6 System Order from Clinic in Florida, US	22.04.
Nexstim Plc Resolved on a New Stock Option Plan 2024H	12.04.
Nexstim Plc: Resolutions of the Annual General Meeting of Shareholders	28.03.
Nexstim Plc: Invitation to the Annual General Meeting	07.03.
Nexstim : Financial Document	06.03.
Nexstim Plc Publishes 2023 Annual Report	06.03.
Nexstim Receives NBS System 5 Order from Neurosurgery Customer in Germany	28.02.
Nexstim Receives NBS System 5 Order from Neurosurgery Customer in Germany	28.02.

Keine Ergebnisse zu dieser Suche